Addiction

KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update

Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid,…

1 year ago

Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

GLEN ALLEN, Va., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage…

1 year ago

KindlyMD to Present at Upcoming August 2024 Investor Conferences

SALT LAKE CITY, UT / ACCESSWIRE / August 13, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first…

1 year ago

TEDCO’s Maryland Innovation Initiative (MII) Announces Recent Investments

$2.1M invested in seven companies to advance innovations from lab to market in Maryland COLUMBIA, Md., Aug. 13, 2024 /PRNewswire/…

1 year ago

Compassion Center Expresses Gratitude to Rebecca Siewert of N.W. Classic and Woodburn Property Management for Highlighting Housing Disparities in Oregon

Compassion Center, headquartered in Hillsboro, Oregon, is a pioneer in integrative healthcare, dedicated to improving global quality of life through…

1 year ago

WVU Medicine To Host Brain-Machine Interface (BMI) Summit Charting the Future of Neurotechnology

Leading Neuroscientists, Technologists, Regulators, and Venture Capitalists Convening in West Virginia MORGANTOWN, W.Va., Aug. 9, 2024 /PRNewswire/ -- West Virginia…

1 year ago

Awakn Announces First Patient Screened in Phase 3 Clinical Trial of AWKN-001 for Severe Alcohol Use Disorder

Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

1 year ago

Kipu Health Launches Medication Assisted Treatment (MAT) Solution Improving Care Experience for Patients in Opioid Treatment Programs (OTPs)

New solution to improve patient treatment unveiled at the United States Association of Opioid Treatment Providers (USAOTP) Annual Conference  AUSTIN,…

1 year ago

ACCP Position Statement: “Unregulated Psychotropic Products”

ASHBURN, Va., Aug. 7, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) published a recent Position Paper entitled "Unregulated…

1 year ago

Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Patient dosing has concluded for the second and last cohort of the pharmacokinetics study of AD04 Topline results expected during…

1 year ago